Pharmaceutical Economics and Policy

Pharmaceutical Economics and Policy examines how economic principles and public policies influence the development, pricing, distribution, and use of medicines within healthcare systems. It focuses on balancing innovation, affordability, access, and sustainability in pharmaceutical markets. Key areas include drug pricing and reimbursement, cost-effectiveness analysis, health technology assessment, patent protection, generic medicines, and regulation of pharmaceutical companies. Pharmaceutical policies aim to ensure that safe, effective, and quality medicines are accessible to populations while controlling rising healthcare costs. From a public health perspective, sound pharmaceutical economics supports rational drug use, equitable access to essential medicines, and efficient allocation of limited resources. Policy decisions affect research and development incentives, availability of life-saving drugs, and health system performance. Evidence-based pharmaceutical policies help governments manage expenditures, promote competition, protect patients, and improve population health outcomes while supporting sustainable and ethical pharmaceutical systems.